Literature DB >> 27039910

[Prophylaxis and treatment of infections in elderly patients with rheumatism].

C Kneitz1, A Strangfeld2, K Krüger3.   

Abstract

In general, the risk of serious infections increases with age, mainly explained by immunosenescence and accumulation of comorbidities. Those patients with rheumatoid arthritis who are of advanced age and require treatment with immunosuppressive agents are at particular risk to develop an infectious disease. Actual requirement and kind of treatment on the one hand, and risk of infection on the other hand, have to be considered carefully for each patient. For example, in high-risk patients, it is important to use glucocorticoids in a minimal way, i.e. in low doses and as short as possible. Vaccination, especially against influenza and pneumococci, plays an essential role in preventing infectious diseases, particularly in the elderly. Nevertheless, in cases of suspected bacterial infection, empiric antibiotic therapy should be started promptly. Due to the burden of drugs taken by patients of advanced age, the benefits and possible side effects as well as potential drug interactions have to be carefully considered. In summary, drug treatment of the elderly requires bearing in mind the complete health status of the individual patient.

Entities:  

Keywords:  Elderly; Rheumatoid arthritis; Risk of infection; Treatment; Vaccination

Mesh:

Substances:

Year:  2014        PMID: 27039910     DOI: 10.1007/s00393-013-1243-5

Source DB:  PubMed          Journal:  Z Rheumatol        ISSN: 0340-1855            Impact factor:   1.372


  39 in total

1.  Influence of replacing tuberculin skin test with ex vivo interferon γ release assays on decision to administer prophylactic antituberculosis antibiotics before anti-TNF therapy.

Authors:  Xavier Mariette; Gabriel Baron; Florence Tubach; Frédéric Lioté; Bernard Combe; Corinne Miceli-Richard; René-Marc Flipo; Philippe Goupille; Matthieu Allez; Dominique Salmon; Dominique Emilie; Guislaine Carcelain; Philippe Ravaud
Journal:  Ann Rheum Dis       Date:  2012-01-17       Impact factor: 19.103

2.  Immunosenescence and Challenges of Vaccination against Influenza in the Aging Population.

Authors:  Adrian J Reber; Tatiana Chirkova; Jin Hyang Kim; Weiping Cao; Renata Biber; David K Shay; Suryaprakash Sambhara
Journal:  Aging Dis       Date:  2011-09-30       Impact factor: 6.745

3.  [Vaccination recommendations of the Commission for Pharmacotherapy of the German Society of Rheumatology].

Authors:  K Warnatz; S Goldacker; A M Gause
Journal:  Z Rheumatol       Date:  2013-09       Impact factor: 1.372

4.  You can't always get what you want, but if you try sometimes (with two tests--TST and IGRA--for tuberculosis) you get what you need.

Authors:  Kevin L Winthrop; Michael E Weinblatt; Charles L Daley
Journal:  Ann Rheum Dis       Date:  2012-09-12       Impact factor: 19.103

Review 5.  Infection in systemic lupus erythematosus.

Authors:  M Petri
Journal:  Rheum Dis Clin North Am       Date:  1998-05       Impact factor: 2.670

6.  Infections in systemic lupus erythematosus: a prospective and controlled study of 110 patients.

Authors:  X Bosch; A Guilabert; L Pallarés; R Cerveral; M Ramos-Casals; A Bové; M Ingelmo; J Font
Journal:  Lupus       Date:  2006       Impact factor: 2.911

Review 7.  [Recommendations for tuberculosis screening before initiation of TNF-alpha-inhibitor treatment in rheumatic diseases].

Authors:  R Diel; B Hauer; R Loddenkemper; B Manger; K Krüger
Journal:  Pneumologie       Date:  2009-06-10

Review 8.  What does epidemiology tell us about risk factors for herpes zoster?

Authors:  Sara L Thomas; Andrew J Hall
Journal:  Lancet Infect Dis       Date:  2004-01       Impact factor: 25.071

9.  Serious infections in a population-based cohort of 86,039 seniors with rheumatoid arthritis.

Authors:  Jessica Widdifield; Sasha Bernatsky; J Michael Paterson; Nadia Gunraj; J Carter Thorne; Janet Pope; Alfred Cividino; Claire Bombardier
Journal:  Arthritis Care Res (Hoboken)       Date:  2013-03       Impact factor: 4.794

10.  Treatment of rheumatoid arthritis with tumor necrosis factor inhibitors may predispose to significant increase in tuberculosis risk: a multicenter active-surveillance report.

Authors:  Juan J Gómez-Reino; Loreto Carmona; Vicente Rodríguez Valverde; Emilio Martín Mola; Maria Dolores Montero
Journal:  Arthritis Rheum       Date:  2003-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.